Seth Tomblyn

Seth Tomblyn is a seasoned professional in the field of biomedical research and product development, with extensive experience in regenerative medicine and therapeutic technologies. Currently serving as a Research Project Analyst at the Medical Technology Enterprise Consortium since September 2022, Seth has previously co-founded Plakous Therapeutics, where innovative approaches to restorative healing using human placenta allografts were explored. Prior roles include Product Development Scientist at Birth Tissue Recovery, LLC, and Principal Scientist at KeraNetics, focusing on protein therapeutics and keratin-based technologies, respectively. Additional experience encompasses various research positions at prominent institutions such as Wake Forest University and Case Western Reserve University, emphasizing controlled release platforms for protein therapeutics. Seth's educational background includes a PhD in Microbiology and Molecular Medicine from Clemson University and an ongoing Executive MBA at UNC Kenan-Flagler Business School.